These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8841672)
1. Screening and treating depressed patients. A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs. patients treated by their family doctors. Danish University Antidepressant Group. Fuglum E; Rosenberg C; Damsbo N; Stage K; Lauritzen L; Bech P Acta Psychiatr Scand; 1996 Jul; 94(1):18-25. PubMed ID: 8841672 [TBL] [Abstract][Full Text] [Related]
2. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Lenox-Smith AJ; Jiang Q Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525 [TBL] [Abstract][Full Text] [Related]
3. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder]. Azorin JM; Llorca PM; Despiegel N; Verpillat P Encephale; 2004; 30(2):158-66. PubMed ID: 15107719 [TBL] [Abstract][Full Text] [Related]
4. Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study. Altamura AC; Dell'Osso B; Buoli M; Zanoni S; Mundo E J Clin Psychopharmacol; 2008 Aug; 28(4):406-10. PubMed ID: 18626267 [TBL] [Abstract][Full Text] [Related]
5. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. Feighner JP; Overø K J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628 [TBL] [Abstract][Full Text] [Related]
6. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings. Gómez Gómez JM; Teixidó Perramón C J Clin Psychiatry; 2000 Apr; 61(4):285-9. PubMed ID: 10830150 [TBL] [Abstract][Full Text] [Related]
7. [Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression]. Bun'kova KM Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):29-32. PubMed ID: 18427538 [TBL] [Abstract][Full Text] [Related]
8. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. Burke WJ; Gergel I; Bose A J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207 [TBL] [Abstract][Full Text] [Related]
9. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group. Psychopharmacology (Berl); 1986; 90(1):131-8. PubMed ID: 2876451 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M; Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886 [TBL] [Abstract][Full Text] [Related]
12. Are gender differences important for the clinical effects of antidepressants? Hildebrandt MG; Steyerberg EW; Stage KB; Passchier J; Kragh-Soerensen P; Am J Psychiatry; 2003 Sep; 160(9):1643-50. PubMed ID: 12944340 [TBL] [Abstract][Full Text] [Related]
13. The effect of citalopram in panic disorder. Wade AG; Lepola U; Koponen HJ; Pedersen V; Pedersen T Br J Psychiatry; 1997 Jun; 170():549-53. PubMed ID: 9330022 [TBL] [Abstract][Full Text] [Related]
14. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Stahl SM Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Kyle CJ; Petersen HE; Overø KF Depress Anxiety; 1998; 8(4):147-53. PubMed ID: 9871816 [TBL] [Abstract][Full Text] [Related]
16. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Bent-Hansen J; Lunde M; Klysner R; Andersen M; Tanghøj P; Solstad K; Bech P Pharmacopsychiatry; 2003 Nov; 36(6):313-6. PubMed ID: 14663657 [TBL] [Abstract][Full Text] [Related]
18. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC; JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799 [TBL] [Abstract][Full Text] [Related]
20. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Lepola UM; Loft H; Reines EH Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]